Doctors and drug companies: is the dangerous liaison drawing to an end?
The Introduction and Overview will contain a bold statement of the essay themes. Next the section on Entanglement will look at the many forms of doctor-drug company relationships, and the evidence for how these can distort practice. Selling Sickness will briefly explore the way doctor-drug company relationships are important to the widening of boundaries of treatable illness. And finally, Disclosure to Disentanglement will look at self-regulatory and statutory attempts around the world to get more independence in the relationship between doctors and drug companies.
Moynihan
Ray
R
University of Newcastle, Australia. Ray.Moynihan@newcastle.edu.au
D016265:Conflict of Interest; D004345:Drug Industry / Q000592:standards*; D004502:Education, Medical, Continuing; D004992:Ethics, Medical; D004995:Ethics, Professional; D006801:Humans; D010820:Physicians / Q000592:standards*; D012201:Reward; D014342:Truth Disclosure